Literature DB >> 23880478

Potential impacts of the Alberta fetal alcohol spectrum disorder service networks on secondary disabilities: a cost-benefit analysis.

Nguyen Xuan Thanh1, Jessica Moffatt, Philip Jacobs, Anderson W Chuck, Egon Jonsson.   

Abstract

OBJECTIVES: To estimate the break-even effectiveness of the Alberta Fetal Alcohol Spectrum Disorder (FASD) Service Networks in reducing occurrences of secondary disabilities associated with FASD.
METHODS: The secondary disabilities addressed within this study include crime, homelessness, mental health problems, and school disruption (for children) or unemployment (for adults). We used a cost-benefit analysis approach where benefits of the service networks were the cost difference between the two approaches: having the 12 service networks and having no service network in place, across Alberta. We used a threshold analysis to estimate the break-even effectiveness (i.e. the effectiveness level at which the service networks became cost-saving).
RESULTS: If no network was in place throughout the province, the secondary disabilities would cost $22.85 million (including $8.62 million for adults and $14.24 million for children) per year. Given the cost of network was $6.12 million per year, the break-even effectiveness was estimated at 28% (range: 25% to 32%). DISCUSSION: Although not all benefits associated with the service networks are included, such as the exclusion of the primary benefit to those experiencing FASD, the benefits to FASD caregivers, and the preventative benefits, the economic and social burden associated with secondary disabilities will "pay-off" if the effectiveness of the program in reducing secondary disabilities is 28%.

Entities:  

Mesh:

Year:  2013        PMID: 23880478

Source DB:  PubMed          Journal:  J Popul Ther Clin Pharmacol        ISSN: 2561-8741


  2 in total

1.  Integrating care for individuals with FASD: results from a multi-stakeholder symposium.

Authors:  Paul Masotti; Sally Longstaffe; Holly Gammon; Jill Isbister; Breann Maxwell; Ana Hanlon-Dearman
Journal:  BMC Health Serv Res       Date:  2015-10-05       Impact factor: 2.655

2.  The cost-effectiveness of screening tools used in the diagnosis of fetal alcohol spectrum disorder: a modelled analysis.

Authors:  Patrick Berrigan; Gail Andrew; James N Reynolds; Jennifer D Zwicker
Journal:  BMC Public Health       Date:  2019-12-27       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.